PHARMACOECONOMIC CLAIMS MUST BE CONSISTENT WITH LABELING, DDMAC STATES IN DRAFT PRINCIPLES ON PE PROMOTION; AGENCY SEEKING COMMENT ON PE CLAIMS
Executive Summary
Pharmacoeconomic claims "must be consistent with, and not contrary to, approved product labeling," the Division of Drug Marketing, Advertising and Communications states in March 20 draft "Principles for the Review of Pharmacoeconomic Promotion."